What is the appropriate treatment for a pericholecystic abscess?

Treatment of Pericholecystic Abscess

For pericholecystic abscess complicating acute cholecystitis, perform laparoscopic cholecystectomy (with open as alternative) combined with antibiotic therapy as the definitive treatment; reserve percutaneous cholecystostomy only for patients with multiple comorbidities who are unfit for surgery. 1

Treatment Algorithm Based on Patient Status

For Surgical Candidates (Immunocompetent, Not Critically Ill)

Definitive Source Control:

• Laparoscopic cholecystectomy is the primary approach, with open cholecystectomy as alternative 1
• Perform surgery as soon as possible, ideally within 7 days of hospital admission and within 10 days of symptom onset 2
• This represents adequate source control for the pericholecystic abscess

Antibiotic Therapy:

• Amoxicillin/Clavulanate 2g/0.2g q8h 1
• Duration: 4 days post-operatively if source control is adequate 1
• For beta-lactam allergy: Eravacycline 1 mg/kg q12h OR Tigecycline 100 mg loading dose then 50 mg q12h 1

For Critically Ill or Immunocompromised Patients

Source Control:

• Still pursue laparoscopic/open cholecystectomy when feasible 1

Antibiotic Therapy:

• Piperacillin/tazobactam 6g/0.75g loading dose, then 4g/0.5g q6h (or 16g/2g continuous infusion) 1
• Duration: Up to 7 days based on clinical conditions and inflammatory markers if source control is adequate 1
• For beta-lactam allergy: Eravacycline 1 mg/kg q12h 1

If Septic Shock:

• Escalate to Meropenem 1g q6h by extended/continuous infusion, OR Doripenem 500mg q8h by extended infusion, OR Imipenem/cilastatin 500mg q6h by extended infusion 1

For High-Risk Surgical Patients (Multiple Comorbidities, Unfit for Surgery)

Cholecystostomy as Bridge or Palliation:

• Percutaneous transhepatic cholecystostomy may be considered when patients do not show clinical improvement after antibiotic therapy 1
• Important caveat: Cholecystostomy is inferior to cholecystectomy in terms of major complications, even in critically ill patients 1
• Antibiotic therapy for 4 days with cholecystostomy 1
• Recent case reports demonstrate this can be used in extreme circumstances (e.g., 89-year-old with MI and heart failure) 3, though mortality remains high in advanced organ dysfunction 4

Special Considerations

Imaging:

• Ultrasound is first-line for diagnosis 1
• CT with IV contrast confirms pericholecystic abscess and guides management 1
• Contrast-enhanced ultrasound can guide cholecystostomy placement and monitor treatment response 5

Inadequate/Delayed Source Control:

• If source control is inadequate or delayed, OR patient at high risk for ESBL-producing Enterobacterales: use Ertapenem 1g q24h OR Eravacycline 1 mg/kg q12h 1

Monitoring:

• Patients with ongoing signs of infection or systemic illness beyond 7 days of antibiotic treatment warrant diagnostic investigation 1

Critical Pitfalls to Avoid

1. Do not delay surgery in surgical candidates - Early cholecystectomy (within 7-10 days) shortens hospital stay and reduces complications 2

2. Do not rely on cholecystostomy as first-line in operable patients - It is explicitly inferior to cholecystectomy even in critically ill patients 1

3. Consider multidrug-resistant organisms - Pericholecystic abscesses can harbor resistant pathogens like Pseudomonas requiring colistin 4

4. Avoid prolonged conservative management - Approximately 30% of conservatively managed patients develop recurrent complications 2